EC Number   |
Specific Activity Minimum [µmol/min/mg] |
Specific Activity Maximum [µmol/min/mg] |
Reference |
|---|
    3.5.4.5 | -999 |
- |
variation between 1.51 to 5.50 nmol/h/mg protein, about 100-fold lower than that in liver |
695606 |
| 3.5.4.5 | 0.00164 |
- |
- |
209531 |
| 3.5.4.5 | 0.0059 |
- |
- |
209532 |
| 3.5.4.5 | 0.011 |
- |
- |
209663 |
| 3.5.4.5 | 0.536 |
- |
activity in non-small cell lung cancer patients with CDA Lys27Lys protein, in 50 mM beta-mercaptoethanol, 0.1 M Tris-HCl, pH 8.0, substrate 0.25 mM gemcitabine |
700510 |
| 3.5.4.5 | 0.7254 |
- |
activity in non-small cell lung cancer patients carrying the Lys27Gln polymorphism and the Gln27Gln polymorphism, in 50 mM beta-mercaptoethanol, 0.1 M Tris-HCl, pH 8.0, substrate 0.25 mM gemcitabine |
700510 |
| 3.5.4.5 | 1.68 |
- |
crude extract, pH 7.5, at 25°C, using 2'-deoxycytidine as substrate |
712889 |
| 3.5.4.5 | 2.35 |
- |
crude extract, pH 7.5, at 25°C, using cytidine as substrate |
712889 |
| 3.5.4.5 | 3.128 |
- |
- |
209492 |
| 3.5.4.5 | 3.3 |
- |
- |
209527 |
